Centessa Pharmaceuticals plc

Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences

BOSTON and LONDON, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop transformational medicines for patients, today announced that members of its management team will participate in the following investor conferences:

Event: Guggenheim 2nd Annual Healthcare Innovation Conference
Date: Wednesday, November 12, 2025
Fireside Chat: 10:30 AM ET

Event: Jefferies Global Healthcare Conference in London
Date: Tuesday, November 18, 2025
Fireside Chat: 2:00 PM GMT/ 9:00 AM ET

Event: 37th Annual Piper Sandler Healthcare Conference
Date: Tuesday, December 2, 2025
Fireside Chat: 3:00 PM ET

Event: 8th Annual Evercore Healthcare Conference
Date: Wednesday, December 3, 2025
Fireside Chat: 9:35 AM ET

Event: Oppenheimer Movers in Rare Disease Summit
Date: Thursday, December 11, 2025

Access to the live webcasts of these events, as well as archived recordings, will be available under the “Events and Publications” tab on the investor relations section of the Centessa Pharmaceuticals website at https://investors.centessa.com/.

About Centessa Pharmaceuticals
Centessa Pharmaceuticals, plc is a clinical-stage pharmaceutical company with a mission to discover, develop and ultimately deliver medicines that are transformational for patients. We are pioneering a new class of potential therapies within our orexin receptor 2 (OX2R) agonist program for the treatment of excessive daytime sleepiness (EDS), impaired attention, cognitive deficits, and fatigue and other symptoms across neurological, neurodegenerative and neuropsychiatric disorders. For more information, visit www.centessa.com, which does not form part of this release.

Contact:
Kristen K. Sheppard, Esq.
SVP of Investor Relations
investors@centessa.com